
Previous studies from Korea have described chronic intestinal pseudo-obstruction (CIPO) patients with transition zone (TZ) in the colon. In this study, we evaluated the pathological characteristics and their association with long-term outcomes in Korean colonic pseudo-obstruction (CPO) patients with TZ.
We enrolled 39 CPO patients who were refractory to medical treatment and underwent colectomy between November 1989 and April 2016 (median age at symptoms onset: 45 [interquartile range, 29–57] years, males 46.2%). The TZ was defined as a colonic segment connecting a proximally dilated and distally non-dilated segment. Detailed pathologic analysis was performed.
Among the 39 patients, 37 (94.9%) presented with TZ and 2 (5.1%) showed no definitive TZ. Median ganglion cell density in the TZ adjusted for the colonic circumference was significantly decreased compared to that in proximal dilated and distal non-dilated segments in TZ (+) patients (9.2 vs 254.3 and 150.5,
Hypoganglionosis can be identified in the TZ of most Korean CPO patients. Detection of other pathological features in addition to TZ-associated hypoganglionosis was associated with poor post-operative outcomes.
Chronic intestinal pseudo-obstruction (CIPO) is a rare, intractable disease characterized by recurrent symptoms of bowel obstruction without demonstrable occluding lesions. Previously, studies evaluating adult CIPO patients have mainly been reported from Western countries.1–4 Most patients described were first diagnosed as having CIPO in their late teens and early 20s, requiring over 5 years from symptom onset to establish a diagnosis. The clinical course of Western CIPO patients is invariably severe2,3 with 80–90% of patients requiring surgery, one-third of patients needing long-term home total parenteral nutrition, and a significant proportion becoming opioid-dependent due to long-standing, severe abdominal pain.1,3,5 The pathology underlying CIPO involves heterogeneous changes including neuropathies, myopathies, and mesenchymopathies (interstitial cells of Cajal [ICC] abnormalities).6,7 Few studies have examined the clinical and pathological characteristics of CIPO in Eastern countries.8
Studies from Korea have reported on a specific group of patients characterized by features of colonic type CIPO with a distinct transition zone (TZ) on macroscopic and microscopic evaluation.9–14 The TZ refers to a focally narrowed colonic segment connecting proximally dilated and distally non-dilated segments. Previous studies from referral centers in Korea indicated 74–79% of patients with colonic pseudo-obstruction (CPO) showed TZ on radiologic studies.13–15 Clinical symptoms of Korean CPO patients with TZ were similar to those of Western CIPO patients. Recurrent sub-occlusive events with abdominal pain, distension, nausea, and vomiting were present and marked dilations of the bowel visualized by computed tomography (CT) scan or radiography were also observed.13,14 However, Korean CPO patients with TZ showed less small bowel involvement14 and favorable clinical course, unlike Western CIPO patients.13–15
Few studies have reported pathological analysis of TZ,9,11,13 in which a significant reduction of ganglion cells defined as segmental hypoganglionosis was found. The number of ICC also decreased in 32.2–60.0% of patients.11,13 Moreover, functional and molecular analysis showed a reduced response to depolarization and a decreased number of neural nitric oxide synthase (nNOS)-positive cells in the TZ.10 However, even in these studies, evaluation was limited to only focal colonic segments, and not to the whole resected colon including the proximally dilated and distally non-dilated segments.11,13
Therefore, our objective was to evaluate Korean CPO patients with radiologically confirmed TZ by detailed pathologic analysis of the resected colon specimen. Next, we assessed the long-term outcomes of TZ-associated CPO patients according to the underlying pathologic characteristics.
This was a retrospective study performed in a tertiary referral center in Seoul, South Korea. Overall, 129 patients were referred with a suspicion of CPO to our center between November 1989 and April 2016. CPO diagnosis was made when patients fulfilled the following criteria: (1) recurrent episodes with symptoms mimicking mechanical obstruction including abdominal pain and abdominal bloating; (2) bowel dilatation and/or intestinal air-fluid levels on abdomen X-ray and/or CT scan; and (3) no evidence of structural disease causing obstruction on upper and lower endoscopy, CT scan, small bowel series, and barium enema.8 Among the 84 CPO-confirmed patients, 38 were managed conservatively, while the remaining 46 underwent colectomy, and of these, 7 patients were excluded because the pathologic specimen was insufficient. Thirty-nine patients were finally enrolled in this study (
All resected specimens were opened, photographed, and fixed with 10% neutral buffered formalin on corkboard. Dilated and apparently normal segments were identified, and maximum and minimum internal circumferences were measured. Segments, which connected dilated and non-dilated areas, were considered TZ. Longitudinal sections for microscopic examination were taken every 10 cm from the proximal to the distal part of the resected specimen. For the TZ, sections were taken contiguously along the long axis of the pathological segment.
Myenteric cell bodies, identified by their characteristic microscopic morphology, such as Nissl substance, large vesicular nuclei, and single prominent nucleoli, were counted per ganglion (
In addition, we counted the number of eosinophils per high power field. Eosinophilic ganglionitis was defined as prominent eosinophilic infiltration in and around the myenteric plexus, the number of which is no less than 10/high power field based on previous case reports.17,18
To identify ganglion cells and ICC, formalin-fixed paraffin-embedded tissue sections were stained with anti-Calretinin antibodies (rabbit monoclonal, clone DC8, Catalog No. 18-0211; dilution 1:400; Zymed, Camarillo; CA, USA,) and anti-CD117 antibodies (rabbit polyclonal, Catalog No. A4502; dilution 1:400; DAKO, Glostrup, Denmark,), respectively. All immunostaining studies were performed using a BenchMark XT automatic immunostaining device with OptiView 3,3′-Diaminobenzidine Immunohistochemistry Detection Kit (Ventana Medical Systems, Tuscon, AZ, USA) according to the manufacturer’s instructions.
We compared the baseline characteristics of CPO patients according to pathological characteristics including the presence of TZ and additional pathologic features. Data including patient demographics, symptoms, results of radiologic studies (abdomen simple X-ray and CT scan), results of endoscopy (upper and lower endoscopy), and laboratory findings were collected by reviewing the medical records. Symptom patterns of patients were classified as follows: (1) acute onset (patients who had symptoms that started within 6 months from CPO diagnosis), (2) acute exacerbation of chronic symptoms (patients whose symptoms were suddenly aggravated and long-standing), and (3) chronic intractable symptoms (patients who had progressive and uncontrolled symptoms lasting more than 6 months).9
The clinical outcomes including disease recurrence, which was defined as re-hospitalization and/or re-operation for treating symptoms and complications of CPO were compared according to the pathologic characteristics. In addition, we evaluated the factors associated with disease recurrence. For patients who had not visited the outpatient department for an extended period, we collected data by telephone interview.
Continuous variables are expressed as medians with inter-quartile ranges (IQRs) and categorical variables as numbers with percentages (%). The chi-squared or Fisher’s exact test was used to compare categorical variables, and the Mann-Whitney
Table 1 shows the clinical characteristics of patients. The median age of symptom onset of the 39 patients enrolled in this study was 45 years (IQR, 29–57 years). The median duration from the symptom onset to CPO diagnosis was 2.0 years (IQR, 1.0–5.3 years). The most common presenting symptom was abdominal distension (92.3%), followed by abdominal pain (79.5%), constipation (76.9%), and nausea/vomiting (35.9%). Among 39 patients, 10 patients (25.6%) had diabetes mellitus and 2 patients (5.1%) had thyroid disease. Sixteen patients (41.0%) had previous history of abdominal surgery. In the abdomen CT scan, small bowel dilation was demonstrated in 23 (59.0%) patients. Among 39 patients, 13 (33.3%) underwent emergency surgery due to intractable gastrointestinal symptoms, particularly when accompanied by signs suggesting septic conditions. Twenty-six patients (66.7%) underwent elective surgery due to symptoms refractory to medical treatment.
The pathologic characteristics of each patient are summarized in Table 2. Overall, 37/39 (94.9%) patients showed pathologically detectable TZ. Median ganglion cell density in the TZ adjusted for the colonic circumference was significantly decreased compared to that in proximal dilated and distal non-dilated segments (9.2 vs 254.3 and 150.5,
Most resected specimens showed marked luminal dilatation in proximal segments and distinctive TZ and non-dilated distal segments. An example (patient No. 13) is shown in Figure 2A. In this specimen, while dilated proximal segments and non-dilated distal segments were present in the myenteric plexus with abundant ganglion cells (Fig. 2B), the TZ and approximately 10 cm of non-dilated segment distal to TZ showed atrophic Schwann cells with markedly decreased ganglion cells (Fig. 2C). The ganglion cell density, calculated by multiplication of the ganglion cell count per centimeter by the mean internal circumference, gradually decreased from the distal part of the TZ, reaching the nadir at the beginning of the distal non-dilated segment (Fig. 2D). The decrease continued along the 10-cm length (the hypoganglionic segment), and the ganglion cell density gradually recovered to its normal level (Fig. 2D). The degree of decrease in ganglion cell density varied from a ratio of 0.5 (hypoganglionic segment [TZ]/normal segment, patient No. 31) to total aganglionosis in affected segments (patient No. 22) (median = 0.10; IQR, 0.06–0.20) and the length of hypoganglionic segments ranged from 5 cm to 120 cm (median = 30 cm; IQR, 20–50 cm) (Table 2). Interestingly, in patient No. 36, two hypoganglionic segments were found separated by an intervening segment with normal ganglion cell density; thus, the gross TZ was located just proximal to the first hypoganglionic segment.
In 6 patients, pathological features other than typical hypoganglionosis included eosinophilic ganglionitis (n = 2), ulcers with/without combined cytomegalovirus (CMV) infection (n = 2), ischemic changes (n = 1), and evidence of heterotopic myenteric plexus (n = 1) (Fig. 3). Eosinophilic ganglionitis (cases No. 24 and 31) was characterized by the infiltration of eosinophils specifically in the myenteric plexus of the distal non-dilated segment (Fig. 3A and 3B). In CMV-infected cases (cases No. 16 and 35), geographic ulcers were observed where several CMV inclusions were identified through immunohistochemistry analysis (Fig. 3C and 3D). CMV ulcers were observed in the proximal dilated segment (patients No. 16 and 35) and distal non-dilated segment (patient No. 16). Patient No. 12 showed a proximal dilated segment with reddish mucosal changes and mucosal necrosis and transmural ischemic changes were observed microscopically (Fig. 3E and 3F). In patient No. 38, the TZ was prominent, but without visible decrease in ganglion cell density (Table 2). Instead, there were several heterotopic myenteric plexuses within the outer longitudinal muscle layer (Fig. 3G and 3H).
Of 39 patients, 2 (5.4%) showed no identifiable TZ (Table 3). In patient No. 37, diffuse hypoganglionosis with ischemic changes was observed (Fig. 4A and 4B). In patient No. 39, there was a severe loss of smooth muscle fibers and interstitial fibrosis, suggesting degenerative myopathy (Fig. 4C and 4D). In cases of the TZ (−) group and atypical TZ without hypoganglionosis (patient No. 38 with heterotopic myenteric plexus), we hypothesized that the differences in ICC number might explain the CPO symptoms. However, the ICC number was not decreased in the TZ of the resected specimen of patient No. 38 and was not significantly decreased in a patient in the TZ (−) group (patient No. 40) compared to normal segments present in the typical TZ group (
We compared clinical characteristics according to pathologic groups. In classic TZ group, 35.8% of patients presented with acute-onset obstructive symptoms. Whereas, only one patient of atypical TZ group had acute-onset symptoms and 66.7% of atypical TZ group complained progressive medically-refractory chronic constipation, although the difference did not reach statistical significance (
We evaluated clinical outcomes according to pathologic groups during the follow-up period (median 5.1 years; IQR, 1.8–8.0 years). In the classic TZ group, 29 patients (93.5%) completely recovered without any residual symptoms after colectomy. However, 3 patients (50.0%) of the atypical TZ group were treated for recurrent sub-occlusive episodes after colectomy (
We evaluated factors associated with symptom recurrence after colectomy in the TZ (+) group (
In this retrospective study including 39 Korean CPO patients, we evaluated the pathologic characteristics of TZ and its relationship with patient outcomes. Overall, 37/39 (94.9%) patients showed evidence of TZ on pathological analysis and segmental hypoganglionosis was demonstrated in the TZ of these Korean CPO patients. Moreover, detection of additional specific pathologic features in association with TZ-associated hypoganglionosis was associated with poor post-surgical outcomes.
Previous reports have described differences in disease characteristics between Korean and Western CIPO patients. The age at diagnosis of Western patients was between the ages of 15 and 30, whereas in Korean CPO patients’ age ranged between 40 to 50 years.1,2 Small bowel abnormalities identified by the dilatation observed in radiologic studies was rare in Korean CPO patients. In Western patients, 36.4–100% showed abnormal findings on small bowel manometry. However, in Korean CPO patients, only 20–60% of patients showed small bowel abnormalities.14,15 The most notable difference regarded disease outcomes. In Western studies, the course of disease has been reported to be severe.1–3,19,20 However, only a limited number of studies evaluated disease outcomes, CPO patients from Korea showed relatively favorable post-operative outcomes.13,15 The TZ, a colonic segment connecting proximally dilated and distally non-dilated segments has been described in Korean CPO patients.9,10,13–15,21
Consistent observations of the TZ in previous studies evaluating Korean CPO patients implied that the distinct clinical characteristics of these patients may be associated with the presence of TZ.9,10,13–15,21 Through detailed pathological analysis of the resected specimens, we found that the ganglion cell density, was significantly decreased in TZ compared to proximal dilated and distal non-dilated segments (
Previously, a group of pediatric patients, mainly from Japan, similar to Korean CPO patients with TZ has been described.11,22–24 These patients were classified as having “allied disease of Hirschsprung’s disease”23 or more commonly as having “acquired isolated hypoganglionosis (AIHG).”22 Although given a different label and patients had a different age range, similar clinical and pathological characteristics as Korean CPO patients with TZ were observed in pediatric AIHG patient group. Above all, a focal intestinal segment with a reduction in the number of ganglion cells was found.11,22,23,25,26 Second, the involved segment was mainly the colon,11,25,26 and the clinical course of this group of patients was relatively favorable.23 We think Korean CPO patients with TZ may be a late-onset form of pediatric AIHG. Taken together Korean CPO with TZ and pediatric AIHG may be a subtype of CPO with favorable outcome, which is more prevalent in Asian countries.
In some cases of pediatric AIHG, eosinophilic infiltration and ischemic changes in addition to segmental hypoganglionosis have been observed.22,25 We found specific pathologic features including, eosinophilic ganglionitis, CMV infection, ischemic changes, heterotopic myenteric plexus in addition to TZ-associated hypoganglionosis in 16.2% of the TZ (+) group. Pediatric AIHG can be ascribed to ischemia and viral infection,22 which may also contribute to ganglion cell degeneration and loss in our CPO patients. An autoimmune mechanism triggered by viral infections, such as herpes simplex virus (HSV) or CMV, may indeed result in loss of ganglion cells as also occurs in some peculiar neuropathies, such as achalasia.27 To confirm this hypothesis, we performed HSV immunostaining in selected cases. However, no HSV positive cells were identified. Further studies with larger sample sizes will be needed to evaluate the etiology and pathogenesis of CPO with TZ.
Herein, a quantitative decrease in ICC along with hypoganglionosis was identified in a subset of cases. However, the ICC decrease was much milder than that of the ganglion cell density and was neither directly proportional to the decrease of ganglion cells nor associated with post-operative outcome. Contrary to our results, there have been conflicting results about the relationship between neuropathy and ICC.11,28 Thus, the clinical impact of ICC depletion in the context of hypoganglionosis should be further evaluated.
Our study has some limitations that should be addressed. First, because we only included patients who were refractory to medical treatment and ultimately underwent surgery, the impact of TZ on the response to medical treatment in Korean CIPO patients was not evaluated. Second, only 2 patients belonged to the TZ (−) group and only one patient with visceral myopathy. This might be due to the lower prevalence of visceral myopathy in the Korean population than in Western countries (5% vs 20%).6,13,15,29 Third, we used H&E staining to detect ganglion cells and did not perform immunostaining using anti-Hu C/D antibody, which is a more precise method. However, the differences in ganglion cell density between hypoganglionic and non-hypoganglionic segments were significant; thus, the inferior precision of H&E staining may be tolerated and would not affect the analysis result as a whole.
In summary, our study determined that Korean CPO patients present distinct characteristics from Western CIPO patients, namely: (1) mainly colon involvement in Korean patients vs small bowel involvement in Western patients; (2) TZ with hypoganglionosis, commonly observed in Korean patients, but rare in Western patients; and (3) relatively good prognosis after removal of the TZ in Korean patients. Considering the decreased ganglion cell density observed in the TZ of most Korean CPO patients, the TZ could be the main site of obstructive symptoms. Mechanisms including ischemia, inflammatory (eosinophilic ganglionitis), and neurotropic virus (CMV) infection can lead to hypoganglionosis. This subset of patients was associated with poor post-operative outcomes. Further studies involving genetic evaluation are required to better elucidate the pathophysiology and specific characteristics of CPO with TZ, which manifests as a typical Eastern phenotype of severe dysmotility.
Note: To access the supplementary tables and figures mentioned in this article, visit the online version of